BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yim J, Lim HH, Kwon Y. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development. Arch Pharm Res 2021;44:499-513. [PMID: 34047940 DOI: 10.1007/s12272-021-01331-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kim HJ, Song JY, Park TI, Choi WS, Kim JH, Kwon OS, Lee JY. The effects of BRL-50481 on ovalbumin-induced asthmatic lung inflammation exacerbated by co-exposure to Asian sand dust in the murine model. Arch Pharm Res 2022. [PMID: 34984603 DOI: 10.1007/s12272-021-01367-x] [Reference Citation Analysis]
2 Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfmüller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, O'Gallagher K, Shah AM, Aguib Y, Yacoub MH. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2021. [PMID: 34873286 DOI: 10.1038/s41569-021-00640-2] [Reference Citation Analysis]
3 Giacomelli C, Piccarducci R, Marchetti L, Romei C, Martini C. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochem Pharmacol 2021;193:114812. [PMID: 34687672 DOI: 10.1016/j.bcp.2021.114812] [Reference Citation Analysis]
4 Sen'kova AV, Savin IA, Brenner EV, Zenkova MA, Markov AV. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study. PLoS One 2021;16:e0260450. [PMID: 34807957 DOI: 10.1371/journal.pone.0260450] [Reference Citation Analysis]
5 Flaifel A, Kwok B, Ko J, Chang S, Smith D, Zhou F, Chiriboga LA, Zeck B, Theise N, Rudym D, Lesko M, Angel L, Moreira A, Narula N. Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation. American Journal of Clinical Pathology 2022. [DOI: 10.1093/ajcp/aqab208] [Reference Citation Analysis]